{"filing":{"accession_number":"0001193125-26-312419","cik":"0001632970","ticker":"AHR","company_name":"American Healthcare REIT, Inc.","form":"8-K","filing_date":"2026-07-22","report_date":null,"primary_document":"ahr-20260720.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1632970/000119312526312419/ahr-20260720.htm"},"events":[{"id":19557,"run_id":17591,"accession_number":"0001193125-26-312419","anchor_item_number":"5.02","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"summary":"Jeffrey Hanson appointed as permanent CEO (effective July 21, 2026) after serving as Interim CEO since February 2026; Gabe Willhite promoted to President and COO; and Scott Estes appointed Lead Independent Director. Danny Prosky retired from his CEO role as part of this leadership succession.","company_name":"American Healthcare REIT, Inc.","ticker":"AHR","filing_date":"2026-07-22","form":"8-K","submitted_at":null,"items":[{"id":18671,"accession_number":"0001193125-26-312419","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses multiple executive appointments and promotions: Jeffrey Hanson appointed as permanent CEO (effective July 21, 2026) after serving as Interim CEO since February 2026; Gabe Willhite promoted to President and COO; and Scott Estes appointed Lead Independent Director. While Danny Prosky's retirement as CEO is also disclosed, the principal action centers on the succession and appointment of Hanson as permanent CEO, making exec_appointment the most salient classification. The compensation arrangements disclosed (base salary, bonuses, RSU grants) are ancillary to the appointment itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T20:20:28.998969+00:00","company_name":"","ticker":null,"filing_date":""},{"id":18672,"accession_number":"0001193125-26-312419","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses multiple executive appointments effective immediately: Jeff Hanson named CEO (in addition to Chairman), Gabe Willhite elevated to President (in addition to COO), and Scott Estes appointed Lead Independent Director. While Danny Prosky's retirement from executive role is also disclosed, the primary focus of the press release and the substantive governance action centers on the appointments of Hanson as CEO and Willhite as President, making exec_appointment the most salient classification. These are material changes to the company's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T20:20:28.998969+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":18671,"accession_number":"0001193125-26-312419","item_number":"5.02","item_title":"Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officer; Compensatory Arrangements of Certain Officers.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"The filing discloses multiple executive appointments and promotions: Jeffrey Hanson appointed as permanent CEO (effective July 21, 2026) after serving as Interim CEO since February 2026; Gabe Willhite promoted to President and COO; and Scott Estes appointed Lead Independent Director. While Danny Prosky's retirement as CEO is also disclosed, the principal action centers on the succession and appointment of Hanson as permanent CEO, making exec_appointment the most salient classification. The compensation arrangements disclosed (base salary, bonuses, RSU grants) are ancillary to the appointment itself.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T20:20:28.998969+00:00","company_name":"American Healthcare REIT, Inc.","ticker":"AHR","filing_date":"2026-07-22"},{"id":18672,"accession_number":"0001193125-26-312419","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"exec_appointment","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The filing discloses multiple executive appointments effective immediately: Jeff Hanson named CEO (in addition to Chairman), Gabe Willhite elevated to President (in addition to COO), and Scott Estes appointed Lead Independent Director. While Danny Prosky's retirement from executive role is also disclosed, the primary focus of the press release and the substantive governance action centers on the appointments of Hanson as CEO and Willhite as President, making exec_appointment the most salient classification. These are material changes to the company's leadership structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-22T20:20:28.998969+00:00","company_name":"American Healthcare REIT, Inc.","ticker":"AHR","filing_date":"2026-07-22"}]}